Detalhe da pesquisa
1.
Phase I study of single-agent ribociclib in Japanese patients with advanced solid tumors.
Cancer Sci
; 109(1): 193-198, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29059492
2.
Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR+, HER2- Advanced Breast Cancer.
Clin Cancer Res
; 26(24): 6417-6428, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998962
3.
Prospects for combining targeted and conventional cancer therapy with immunotherapy.
Nat Rev Cancer
; 17(5): 286-301, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28338065
4.
Complete regression of large solid tumors using engineered drug-resistant hematopoietic cells and anti-CD137 immunotherapy.
Hum Gene Ther
; 17(8): 798-806, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16942440
5.
Rationale for anti-GITR cancer immunotherapy.
Eur J Cancer
; 67: 1-10, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27591414
6.
Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.
J Clin Oncol
; 27(23): 3822-9, 2009 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19581539
7.
T cell costimulatory and inhibitory receptors as therapeutic targets for inducing anti-tumor immunity.
Curr Cancer Drug Targets
; 7(1): 55-70, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17305478
8.
Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice.
J Immunol
; 178(7): 4194-213, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17371976
9.
Highly efficient transduction of repopulating bone marrow cells using rapidly concentrated polymer-complexed retrovirus.
Biochem Biophys Res Commun
; 330(3): 768-75, 2005 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-15809063